There was a suggestion that the incidence of BCC was higher for infliximab compared with nbDMARD than for etanercept or adalimumab, although this finding did not reach statistical significance.
← all excerpts
The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register.
1
—
—